ICCM News and Press, IceCure Medical Ltd. From 09/05/23

IceCure Medical's ProSense Cryoablation System Receives Regulatory Approval in Brazil PR Newswire $6.6 million in sales expected in Brazilian market over the next five years per distribution agreement guarantees High level of early interest in ProSense...

IceCure Medical Takes Next Major Initiative as it Prepares to Accelerate the Commercialization of ProSense in U.S. and Canada: Appoints VP of Sales, North America PR Newswire Mr. Shad Good brings nearly 20 years of medical device sales and leadership experience, includ...

IceCure Medical Continues to Experience Growing Global Interest in ProSense: Featured at the 16th Thai Breast Symposium PR Newswire Professor Eisuke Fukuma, who has performed over 600 ProSense breast cancer cryoablation procedures, led a cryoablation symposium with Pr...

2023-08-14 16:05:05 ET IceCure Medical Ltd (ICCM) Q2 2023 Earnings Conference Call August 14, 2023, 10:00 AM ET Company Participants Todd Kehrli - EVC Group, Investor Relations Eyal Shamir - Chief Executive Officer Ronen Tsimerman - Chief Financial Officer and Ch...

2023-08-14 08:43:42 ET IceCure Medical press release ( NASDAQ: ICCM ): 1H GAAP EPS of -$0.168. Revenue of $1.64M (+8.6% Y/Y). For further details see: IceCure Medical GAAP EPS of -$0.168, revenue of $1.64M

IceCure Medical Reports First Half 2023 Financial & Operational Results: Global Adoption of Cryoablation Technology Gaining Momentum IceCure Medical Reports First Half 2023 Financial & Operational Results: Global Adoption of Cryoablation Technology Gaining Momentum PR Newswi...

IceCure Medical to Report Second Quarter 2023 Financial & Operational Results on August 14, 2023 IceCure Medical to Report Second Quarter 2023 Financial & Operational Results on August 14, 2023 PR Newswire CAESAREA, Israel , Aug. 7, 2023 /PRNewswire/ ...

Health Canada Approves IceCure Medical's Minimally Invasive ProSense Cryoablation System PR Newswire Strong interest in ProSense from healthcare providers in Canada strengthens market potential ProSense now approved throughout North America ...

2023-07-17 08:16:34 ET Quoin Pharmaceuticals ( QNRX ) -91% . BYND Cannasoft Enterprises ( BCAN ) -47% . Apellis Pharmaceuticals ( APLS ) -33% . Baosheng Media Group Holdings Limited ( BAOS ) -13% . Ebix ( EBIX ) -11% after clarific...

IceCure Medical Expands Distribution of ProSense® into Portugal Through Agreement with Medicinália Cormédica: Upfront Systems & Probes Sales IceCure Medical Expands Distribution of ProSense® into Portugal Through Agreement with Medicinália Cormédica: Up...